Increased abundance of anti-apoptotic BCL-2, BCL-XL or MCL-1 is found in several B-cell malignancies, including diffuse large B-cell lymphoma (DLBCL), thereby counteracting pro-apoptotic signaling induced by oncogenic stress [13]. Here, BCL2 is linked to diffuse large B-cell lymphoma.